These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21315269)

  • 21. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.
    Yoshii Y; Yoneda M; Ikawa M; Furukawa T; Kiyono Y; Mori T; Yoshii H; Oyama N; Okazawa H; Saga T; Fujibayashi Y
    Nucl Med Biol; 2012 Feb; 39(2):177-85. PubMed ID: 22033022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
    Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
    Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
    Dehdashti F; Grigsby PW; Mintun MA; Lewis JS; Siegel BA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1233-8. PubMed ID: 12654432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2.
    Li F; Jørgensen JT; Forman J; Hansen AE; Kjaer A
    J Nucl Med; 2016 Mar; 57(3):437-43. PubMed ID: 26585061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission.
    McMillan DD; Maeda J; Bell JJ; Genet MD; Phoonswadi G; Mann KA; Kraft SL; Kitamura H; Fujimori A; Yoshii Y; Furukawa T; Fujibayashi Y; Kato TA
    J Radiat Res; 2015 Sep; 56(5):784-91. PubMed ID: 26251463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.
    Nie X; Randolph GJ; Elvington A; Bandara N; Zheleznyak A; Gropler RJ; Woodard PK; Lapi SE
    Nucl Med Biol; 2016 Sep; 43(9):534-542. PubMed ID: 27372286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.
    Obata A; Yoshimi E; Waki A; Lewis JS; Oyama N; Welch MJ; Saji H; Yonekura Y; Fujibayashi Y
    Ann Nucl Med; 2001 Dec; 15(6):499-504. PubMed ID: 11831397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
    Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
    J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).
    Dehdashti F; Grigsby PW; Lewis JS; Laforest R; Siegel BA; Welch MJ
    J Nucl Med; 2008 Feb; 49(2):201-5. PubMed ID: 18199612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.
    Ballegeer EA; Madrill NJ; Berger KL; Agnew DW; McNiel EA
    BMC Cancer; 2013 Apr; 13():218. PubMed ID: 23631652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
    Burgman P; O'Donoghue JA; Lewis JS; Welch MJ; Humm JL; Ling CC
    Nucl Med Biol; 2005 Aug; 32(6):623-30. PubMed ID: 16026709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620.
    Hsu CS; Tung CY; Yang CY; Lin CH
    PLoS One; 2013; 8(4):e61133. PubMed ID: 23577199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
    Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR
    J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
    Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
    J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT.
    Hansen AE; Kristensen AT; Law I; McEvoy FJ; Kjær A; Engelholm SA
    Radiother Oncol; 2012 Mar; 102(3):424-8. PubMed ID: 22119225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of
    Toriihara A; Ohtake M; Tateishi K; Hino-Shishikura A; Yoneyama T; Kitazume Y; Inoue T; Kawahara N; Tateishi U
    Ann Nucl Med; 2018 May; 32(4):264-271. PubMed ID: 29453680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix.
    Grigsby PW; Malyapa RS; Higashikubo R; Schwarz JK; Welch MJ; Huettner PC; Dehdashti F
    Mol Imaging Biol; 2007; 9(5):278-83. PubMed ID: 17431727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia.
    McCall KC; Humm JL; Bartlett R; Reese M; Carlin S
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e393-9. PubMed ID: 22727887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.